vs

Side-by-side financial comparison of Creative Media & Community Trust Corp (CMCT) and STEM, INC. (STEM). Click either name above to swap in a different company.

STEM, INC. is the larger business by last-quarter revenue ($47.1M vs $28.5M, roughly 1.7× Creative Media & Community Trust Corp). STEM, INC. runs the higher net margin — -33.9% vs -125.8%, a 91.9% gap on every dollar of revenue. On growth, Creative Media & Community Trust Corp posted the faster year-over-year revenue change (3.6% vs -15.6%). Over the past eight quarters, STEM, INC.'s revenue compounded faster (36.1% CAGR vs -8.5%).

Creative Media & Community Trust Corp is a U.S.-headquartered real estate investment trust operating two core segments: it owns, manages and develops creative media facilities including professional film and TV production studios, plus community-focused assets such as affordable housing, neighborhood healthcare centers and local commercial spaces, serving media operators and local communities nationwide.

StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.

CMCT vs STEM — Head-to-Head

Bigger by revenue
STEM
STEM
1.7× larger
STEM
$47.1M
$28.5M
CMCT
Growing faster (revenue YoY)
CMCT
CMCT
+19.2% gap
CMCT
3.6%
-15.6%
STEM
Higher net margin
STEM
STEM
91.9% more per $
STEM
-33.9%
-125.8%
CMCT
Faster 2-yr revenue CAGR
STEM
STEM
Annualised
STEM
36.1%
-8.5%
CMCT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CMCT
CMCT
STEM
STEM
Revenue
$28.5M
$47.1M
Net Profit
$-11.4M
$-16.0M
Gross Margin
48.9%
Operating Margin
-125.6%
-17.7%
Net Margin
-125.8%
-33.9%
Revenue YoY
3.6%
-15.6%
Net Profit YoY
-11.4%
68.8%
EPS (diluted)
$-3.89
$-4.40

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CMCT
CMCT
STEM
STEM
Q4 25
$28.5M
$47.1M
Q3 25
$26.2M
$38.2M
Q2 25
$29.7M
$38.4M
Q1 25
$32.3M
$32.5M
Q4 24
$27.5M
$55.8M
Q3 24
$28.6M
$29.3M
Q2 24
$34.4M
$34.0M
Q1 24
$34.0M
$25.5M
Net Profit
CMCT
CMCT
STEM
STEM
Q4 25
$-11.4M
$-16.0M
Q3 25
$-12.5M
$-23.8M
Q2 25
$-9.0M
$202.5M
Q1 25
$-6.1M
$-25.0M
Q4 24
$-10.3M
$-51.1M
Q3 24
$-10.4M
$-148.3M
Q2 24
$-796.0K
$-582.3M
Q1 24
$-3.7M
$-72.3M
Gross Margin
CMCT
CMCT
STEM
STEM
Q4 25
48.9%
Q3 25
35.5%
Q2 25
33.4%
Q1 25
32.4%
Q4 24
-4.4%
Q3 24
21.2%
Q2 24
27.6%
Q1 24
-95.0%
Operating Margin
CMCT
CMCT
STEM
STEM
Q4 25
-125.6%
-17.7%
Q3 25
-47.7%
-33.6%
Q2 25
-30.3%
-34.8%
Q1 25
-19.0%
-65.0%
Q4 24
-128.8%
-84.4%
Q3 24
-36.9%
-493.2%
Q2 24
-1.6%
-1705.5%
Q1 24
-10.7%
-267.0%
Net Margin
CMCT
CMCT
STEM
STEM
Q4 25
-125.8%
-33.9%
Q3 25
-47.5%
-62.2%
Q2 25
-30.3%
527.8%
Q1 25
-18.9%
-76.9%
Q4 24
-129.8%
-91.6%
Q3 24
-36.3%
-506.3%
Q2 24
-2.3%
-1712.6%
Q1 24
-11.0%
-283.9%
EPS (diluted)
CMCT
CMCT
STEM
STEM
Q4 25
$-3.89
$-4.40
Q3 25
$-23.52
$-2.84
Q2 25
$-18.94
$-1.79
Q1 25
$-20.73
$-0.15
Q4 24
$97.71
$-15.29
Q3 24
$-305.04
$-18.24
Q2 24
$-98.64
$-71.81
Q1 24
$-125.46
$-0.46

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CMCT
CMCT
STEM
STEM
Cash + ST InvestmentsLiquidity on hand
$15.4M
$48.9M
Total DebtLower is stronger
$509.8M
Stockholders' EquityBook value
$265.4M
$-249.4M
Total Assets
$859.2M
$308.9M
Debt / EquityLower = less leverage
1.92×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CMCT
CMCT
STEM
STEM
Q4 25
$15.4M
$48.9M
Q3 25
$17.3M
$43.1M
Q2 25
$27.8M
$40.8M
Q1 25
$19.8M
$58.6M
Q4 24
$20.3M
$56.3M
Q3 24
$18.5M
$75.4M
Q2 24
$29.3M
$89.6M
Q1 24
$21.3M
$112.8M
Total Debt
CMCT
CMCT
STEM
STEM
Q4 25
$509.8M
Q3 25
$527.8M
Q2 25
$535.6M
Q1 25
$512.7M
Q4 24
$505.7M
Q3 24
$478.3M
Q2 24
$485.1M
Q1 24
$472.8M
Stockholders' Equity
CMCT
CMCT
STEM
STEM
Q4 25
$265.4M
$-249.4M
Q3 25
$281.9M
$-235.7M
Q2 25
$287.1M
$-214.1M
Q1 25
$293.0M
$-417.5M
Q4 24
$304.5M
$-398.4M
Q3 24
$321.0M
$-344.1M
Q2 24
$351.1M
$-203.2M
Q1 24
$369.9M
$371.6M
Total Assets
CMCT
CMCT
STEM
STEM
Q4 25
$859.2M
$308.9M
Q3 25
$871.8M
$362.6M
Q2 25
$885.0M
$379.2M
Q1 25
$882.3M
$405.1M
Q4 24
$889.6M
$437.4M
Q3 24
$868.0M
$537.8M
Q2 24
$891.2M
$691.5M
Q1 24
$887.5M
$1.3B
Debt / Equity
CMCT
CMCT
STEM
STEM
Q4 25
1.92×
Q3 25
1.87×
Q2 25
1.87×
Q1 25
1.75×
Q4 24
1.66×
Q3 24
1.49×
Q2 24
1.38×
Q1 24
1.28×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CMCT
CMCT
STEM
STEM
Operating Cash FlowLast quarter
$5.8M
$8.2M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CMCT
CMCT
STEM
STEM
Q4 25
$5.8M
$8.2M
Q3 25
$3.7M
$11.4M
Q2 25
$-2.5M
$-21.3M
Q1 25
$1.2M
$8.5M
Q4 24
$17.0M
$-14.7M
Q3 24
$10.3M
$-9.4M
Q2 24
$3.9M
$-11.9M
Q1 24
$1.6M
$-621.0K
Cash Conversion
CMCT
CMCT
STEM
STEM
Q4 25
Q3 25
Q2 25
-0.11×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons